Cargando…
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may result in a severe pneumonia associated with elevation of blood inflammatory parameters, reminiscent of cytokine storm syndrome. Steroidal anti-inflammatory therapies have shown efficacy in reducing mortality in c...
Autores principales: | Bertoni, Arinna, Penco, Federica, Mollica, Hilaria, Bocca, Paola, Prigione, Ignazia, Corcione, Anna, Cangelosi, Davide, Schena, Francesca, Del Zotto, Genny, Amaro, Adriana, Paladino, Noemi, Pontali, Emanuele, Feasi, Marcello, Signa, Sara, Bustaffa, Marta, Caorsi, Roberta, Palmeri, Serena, Contini, Paola, De Palma, Raffaele, Pfeffer, Ulrich, Uva, Paolo, Rubartelli, Anna, Gattorno, Marco, Volpi, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272569/ https://www.ncbi.nlm.nih.gov/pubmed/35835255 http://dx.doi.org/10.1016/j.jaci.2022.05.029 |
Ejemplares similares
-
An Update on Familial Mediterranean Fever
por: Lancieri, Maddalena, et al.
Publicado: (2023) -
Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity
por: Signa, Sara, et al.
Publicado: (2022) -
Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome
por: Matucci‐Cerinic, Caterina, et al.
Publicado: (2022) -
Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
por: Pontali, Emanuele, et al.
Publicado: (2020) -
Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia
por: Pontali, Emanuele, et al.
Publicado: (2021)